The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy
Open Access
- 21 November 2007
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 117 (12), 3730-3741
- https://doi.org/10.1172/jci32967
Abstract
The clinical utility of anthracycline anticancer agents, especially doxorubicin, is limited by a progressive toxic cardiomyopathy linked to mitochondrial damage and cardiomyocyte apoptosis. Here we demonstrate that the post-doxorubicin mouse heart fails to upregulate the nuclear program for mitochondrial biogenesis and its associated intrinsic antiapoptosis proteins, leading to severe mitochondrial DNA (mtDNA) depletion, sarcomere destruction, apoptosis, necrosis, and excessive wall stress and fibrosis. Furthermore, we exploited recent evidence that mitochondrial biogenesis is regulated by the CO/heme oxygenase (CO/HO) system to ameliorate doxorubicin cardiomyopathy in mice. We found that the myocardial pathology was averted by periodic CO inhalation, which restored mitochondrial biogenesis and circumvented intrinsic apoptosis through caspase-3 and apoptosis-inducing factor. Moreover, CO simultaneously reversed doxorubicin-induced loss of DNA binding by GATA-4 and restored critical sarcomeric proteins. In isolated rat cardiac cells, HO-1 enzyme overexpression prevented doxorubicin-induced mtDNA depletion and apoptosis via activation of Akt1/PKB and guanylate cyclase, while HO-1 gene silencing exacerbated doxorubicin-induced mtDNA depletion and apoptosis. Thus doxorubicin disrupts cardiac mitochondrial biogenesis, which promotes intrinsic apoptosis, while CO/HO promotes mitochondrial biogenesis and opposes apoptosis, forestalling fibrosis and cardiomyopathy. These findings imply that the therapeutic index of anthracycline cancer chemotherapeutics can be improved by the protection of cardiac mitochondrial biogenesis.This publication has 51 references indexed in Scilit:
- A new activating role for CO in cardiac mitochondrial biogenesisJournal of Cell Science, 2007
- NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failureCardiovascular Research, 2006
- Carbon monoxide, oxidative stress, and mitochondrial permeability pore transitionFree Radical Biology & Medicine, 2006
- The Mitochondrial Biogenesis Regulatory Program in Cardiac Adaptation to Ischemia—A Putative Target for Therapeutic InterventionTrends in Cardiovascular Medicine, 2005
- Apoptosis-Inducing Factor Substitutes for Caspase Executioners in NMDA-Triggered Excitotoxic Neuronal DeathJournal of Neuroscience, 2004
- CARBON MONOXIDE ACTUATES O2-LIMITED HEME DEGRADATION IN THE RAT BRAINFree Radical Biology & Medicine, 2004
- Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric OxideScience, 2003
- DNA binding is required for the apoptogenic action of apoptosis inducing factorNature Structural & Molecular Biology, 2002
- Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing FactorScience, 2002
- The effect of first-dose doxorubicin on the cyclic nucleotide levels of the human myocardiumToxicology and Applied Pharmacology, 1981